Abnormal Prefrontal Development in Pediatric Posttraumatic Stress Disorder: A Longitudinal Structural and Functional Magnetic Resonance Imaging Study.


Journal

Biological psychiatry. Cognitive neuroscience and neuroimaging
ISSN: 2451-9030
Titre abrégé: Biol Psychiatry Cogn Neurosci Neuroimaging
Pays: United States
ID NLM: 101671285

Informations de publication

Date de publication:
02 2019
Historique:
received: 29 03 2018
revised: 27 07 2018
accepted: 27 07 2018
pubmed: 22 10 2018
medline: 7 1 2020
entrez: 22 10 2018
Statut: ppublish

Résumé

Prior studies of pediatric posttraumatic stress disorder (PTSD) have reported cross-sectional and age-related structural and functional brain abnormalities in networks associated with cognitive, affective, and self-referential processing. However, no reported studies have comprehensively examined longitudinal gray matter development and its intrinsic functional correlates in pediatric PTSD. Twenty-seven youths with PTSD and 21 nontraumatized typically developing (TD) youths were assessed at baseline and 1-year follow-up. At each visit, youths underwent structural magnetic resonance imaging and resting-state functional magnetic resonance imaging. Regions with volumetric abnormalities in whole-brain structural analyses were identified and used as seeds in exploratory intrinsic connectivity analyses. Youths with PTSD exhibited sustained reductions in gray matter volume (GMV) in right ventromedial prefrontal cortex (PFC) and bilateral ventrolateral PFC. Group-by-time analyses revealed aberrant longitudinal development in dorsolateral PFC, where typically developing youths exhibited normative decreases in GMV between baseline and follow-up, and youths with PTSD showed increases in GMV. Using these regions as seeds, patients with PTSD exhibited atypical longitudinal decreases in intrinsic PFC-amygdala and PFC-hippocampus connectivity, in contrast to increases in typically developing youths. Specifically, youths with PTSD showed decreasing ventromedial PFC-amygdala connectivity as well as decreasing ventrolateral PFC-hippocampus connectivity over time. Notably, volumetric abnormalities in ventromedial PFC and ventrolateral PFC were predictive of symptom severity. These findings represent novel longitudinal volumetric and connectivity changes in pediatric PTSD. Atypical prefrontal GMV and prefrontal-amygdala/hippocampus development may underlie persistence of PTSD in youths and could serve as future therapeutic targets.

Sections du résumé

BACKGROUND
Prior studies of pediatric posttraumatic stress disorder (PTSD) have reported cross-sectional and age-related structural and functional brain abnormalities in networks associated with cognitive, affective, and self-referential processing. However, no reported studies have comprehensively examined longitudinal gray matter development and its intrinsic functional correlates in pediatric PTSD.
METHODS
Twenty-seven youths with PTSD and 21 nontraumatized typically developing (TD) youths were assessed at baseline and 1-year follow-up. At each visit, youths underwent structural magnetic resonance imaging and resting-state functional magnetic resonance imaging. Regions with volumetric abnormalities in whole-brain structural analyses were identified and used as seeds in exploratory intrinsic connectivity analyses.
RESULTS
Youths with PTSD exhibited sustained reductions in gray matter volume (GMV) in right ventromedial prefrontal cortex (PFC) and bilateral ventrolateral PFC. Group-by-time analyses revealed aberrant longitudinal development in dorsolateral PFC, where typically developing youths exhibited normative decreases in GMV between baseline and follow-up, and youths with PTSD showed increases in GMV. Using these regions as seeds, patients with PTSD exhibited atypical longitudinal decreases in intrinsic PFC-amygdala and PFC-hippocampus connectivity, in contrast to increases in typically developing youths. Specifically, youths with PTSD showed decreasing ventromedial PFC-amygdala connectivity as well as decreasing ventrolateral PFC-hippocampus connectivity over time. Notably, volumetric abnormalities in ventromedial PFC and ventrolateral PFC were predictive of symptom severity.
CONCLUSIONS
These findings represent novel longitudinal volumetric and connectivity changes in pediatric PTSD. Atypical prefrontal GMV and prefrontal-amygdala/hippocampus development may underlie persistence of PTSD in youths and could serve as future therapeutic targets.

Identifiants

pubmed: 30343133
pii: S2451-9022(18)30188-5
doi: 10.1016/j.bpsc.2018.07.013
pmc: PMC6371792
mid: NIHMS986901
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-179

Subventions

Organisme : NIMH NIH HHS
ID : K08 MH100267
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR000429
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000427
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002373
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Biol Psychiatry. 2013 Jan 1;73(1):70-4
pubmed: 22840760
Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):427-434
pubmed: 28394502
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Apr;3(4):311-319
pubmed: 29628063
Neuron. 2008 Sep 25;59(6):1037-50
pubmed: 18817740
Depress Anxiety. 2001;13(3):132-56
pubmed: 11387733
Neuroimage. 2014 Jul 15;95:193-207
pubmed: 24662579
CNS Neurosci Ther. 2011 Aug;17(4):227-36
pubmed: 20406268
Biol Psychiatry. 2008 Mar 15;63(6):577-86
pubmed: 17888411
Neuropsychopharmacology. 2015 Feb;40(3):537-45
pubmed: 25212487
Pediatrics. 2007 Mar;119(3):509-16
pubmed: 17332204
Anat Embryol (Berl). 2005 Dec;210(5-6):343-52
pubmed: 16208455
Neuropsychopharmacology. 2016 Feb;41(3):791-801
pubmed: 26171720
Cereb Cortex. 2014 Nov;24(11):2981-90
pubmed: 23765157
Psychiatry Res. 2013 Dec 30;214(3):238-46
pubmed: 23969000
Arch Pediatr Adolesc Med. 2011 Jan;165(1):16-21
pubmed: 21199975
Neuropsychopharmacology. 2016 Nov;41(12):2903-2912
pubmed: 27329685
Soc Cogn Affect Neurosci. 2012 Jan;7(1):11-22
pubmed: 22228751
Biol Psychiatry. 2002 Dec 1;52(11):1066-78
pubmed: 12460690
Neuropsychopharmacology. 2016 Feb;41(3):822-31
pubmed: 26171717
Am J Psychiatry. 2017 Dec 1;174(12):1175-1184
pubmed: 28715907
Philos Trans R Soc Lond B Biol Sci. 2007 May 29;362(1481):917-32
pubmed: 17412678
Biol Psychiatry. 2001 Aug 15;50(4):305-9
pubmed: 11522266
Ann N Y Acad Sci. 2004 Dec;1032:154-7
pubmed: 15677402
Hum Brain Mapp. 2016 Mar;37(3):1120-35
pubmed: 26859310
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):545-53
pubmed: 9100430
Biol Psychiatry. 2003 Oct 1;54(7):693-702
pubmed: 14512209
Psychiatry Res. 2003 Aug 1;119(3):225-41
pubmed: 12914894
J Am Acad Child Adolesc Psychiatry. 2013 Aug;52(8):815-830.e14
pubmed: 23880492
Neuroimage. 2013 Jun;73:176-90
pubmed: 23376789
Nature. 2002 Nov 7;420(6911):70-4
pubmed: 12422216
J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):726-37
pubmed: 3058677
Curr Psychiatry Rep. 2017 Aug 19;19(10):69
pubmed: 28823091
Science. 2003 Aug 8;301(5634):805-9
pubmed: 12907793
Curr Psychiatry Rep. 2004 Apr;6(2):96-100
pubmed: 15038911
Biol Psychiatry. 2001 Dec 15;50(12):943-51
pubmed: 11750890
J Child Psychol Psychiatry. 2016 Mar;57(3):241-66
pubmed: 26831814
Neuropsychopharmacology. 2016 Jan;41(2):611-8
pubmed: 26111649

Auteurs

Sara A Heyn (SA)

Neuroscience and Public Policy Program, University of Wisconsin-Madison, Madison, Wisconsin; Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin. Electronic address: sheyn@wisc.edu.

Taylor J Keding (TJ)

Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin.

Marisa C Ross (MC)

Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin.

Josh M Cisler (JM)

Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin; Department of Psychiatry, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.

Jeanette A Mumford (JA)

Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin.

Ryan J Herringa (RJ)

Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin; Department of Psychiatry, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH